Alexanders vs Saul Centers
ALX and BFS side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ALX and BFS compare
Alexanders is the larger company, worth 1.8 times as much as Saul Centers ($1.3B against $719M).
On earnings, Alexanders is cheaper: it trades at 7.6× trailing earnings, against 30.0× for Saul Centers.
Saul Centers grew revenue faster over the last twelve months (8.7% versus −1.5% for Alexanders).
Alexanders keeps more of each dollar of sales as profit, with a net margin of 79.1% compared with 11.5% at Saul Centers.
Both pay dividends: Alexanders yields 7.2% and Saul Centers 8.1%.
Alexanders scores higher on the StockData Score (18 against 10 for Saul Centers), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ALX | BFS |
|---|---|---|
| Size and price | ||
| Market cap | $1.3B | $719M |
| Share price | $251.62 | $29.09 |
| Change, 1 year | 12.8% | −2.2% |
| Change, 5 years | −9.9% | −43.2% |
| Beta (5Y) | 0.65 | 0.75 |
| Employees | 69 | 70 |
| StockData Score | ||
| Total score | 18 (better) | 10 |
| Valuation score | 4 (better) | 2 |
| Growth score | 1 | 1 |
| Performance score | 4 (better) | 3 |
| Health score | 4 (better) | 0 |
| Dividend score | 5 (better) | 4 |
| Valuation | ||
| P/E | 7.6× (better) | 30.0× |
| P/S | 6.0× | 2.4× (better) |
| P/B | 5.7× | 2.4× (better) |
| EV/EBITDA | – | 3.4× |
| Fair value | $560.13 | $59.07 |
| Margin of safety | 55.1% (better) | 50.8% |
| Growth | ||
| Revenue growth (TTM) | −1.5% | 8.7% (better) |
| Revenue growth, 5Y average | 1.4% | 5.2% (better) |
| Net income growth (TTM) | 354% (better) | −19.1% |
| EPS growth (TTM) | 354% (better) | −26.5% |
| EPS growth, 5Y average | −7.7% | −2.7% (better) |
| Profitability | ||
| Operating margin | – | 67.0% |
| Net margin | 79.1% (better) | 11.5% |
| Return on equity | 92.0% (better) | 11.3% |
| Return on invested capital | – | 52.7% |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | 2.6× |
| Altman Z-score | 1.18 (better) | 0.47 |
| Piotroski F-score | 4 | 5 (better) |
| Dividends and buybacks | ||
| Dividend yield | 7.2% | 8.1% (better) |
| Payout ratio | 54.4% | 165% |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | 0.00% | 2.2% (better) |
| Buyback yield | – | −0.68% |
| Shareholder yield | 7.2% | 7.4% (better) |
| Ownership | ||
| Held by institutions | 39.1% | 47.6% |
| Held by insiders | 48.7% | 4.2% |
| Insider net buying, 12 months | −$113K | $332K (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 10.0% | 2.1% |
Go deeper
- ALX stock overview
- ALX income statement
- ALX valuation and score
- BFS stock overview
- BFS income statement
- BFS valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.